Pozen, Inc. Welcomes Dr. Seth A. Rudnick to the Board of Directors

July 27, 2011 |

1 min read

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced the election of Seth A. Rudnick, M.D., to its Board of Directors.

People

MORE ON THIS TOPIC

Illustration showing hands holding arrow that goes up and down a few times and ends up in upward direction

Mergers & acquisitions

Rumors of Eli Lilly Buyout Send Nektar’s Shares Spiking

October 20, 2025

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Following Cancelled FDA Meeting, Kezar To Cut Employees, Eyes Strategic Alternatives

October 17, 2025

·

73 min read

·

BioSpace Editorial Staff

background, no people

Drug pricing

Novo, Lilly Shares Drop as Trump Promises $150 Ozempic

October 17, 2025

·

3 min read

·

Annalee Armstrong

Pleasanton, CA, USA - Feb 21, 2024: Exterior view of the headquarters of Roche Molecular Diagnostics (RMD) in Pleasanton, California. F. Hoffmann-La Roche AG is a Swiss pharmaceutical company.

Antibody-drug conjugate (ADC)

Roche Inks Another China ADC Pact With $1.5B Hansoh Bet

October 17, 2025

·

2 min read

·

Tristan Manalac